Archean Chemical has multiple MOATS & Robust long-term growth outlook

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Dec 24, 2023.

Tags:
Previous Thread Next Thread
Loading...
  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    756
    Likes Received:
    55
    Archean Chemical has multiple MOATS & Robust long-term growth outlook. China is Big Consumer, Not Competitor. Forward integration into high-value business with strong demand. Well-nurtured long-term relationship with customers. Target price Rs 810 (33% gain)

    Download research report

    [​IMG]
     
    Vidhi Khanna, Dec 24, 2023
    #1
Previous Thread Next Thread
Loading...
Loading...
Similar Threads
  1. Vidhi Khanna

    Buy Archean Chemical for target price of ₹943 (58% upside)

    Vidhi Khanna, Oct 28, 2024, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    472
    Vidhi Khanna
    Oct 28, 2024
  2. Vidhi Khanna

    Archean Chemical has strong moats around its business. TP ₹1158 (+50% upside)

    Vidhi Khanna, Aug 28, 2024, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    354
    Vidhi Khanna
    Aug 28, 2024
  3. Vidhi Khanna

    Archean is a robust play on the expanding footprint in high-growth derivative & technology sectors.

    Vidhi Khanna, Dec 7, 2024, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    713
    Vidhi Khanna
    Dec 7, 2024
  4. Vidhi Khanna

    Sudarshan Chemicals has access to cutting-edge technologies & can enhance its portfolio

    Vidhi Khanna, Oct 16, 2024, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    403
    Vidhi Khanna
    Oct 16, 2024
  5. Vidhi Khanna

    JB Chemicals is a potent fusion; reiterate BUY with FV of Rs2,255 (23% upside)

    Vidhi Khanna, Oct 1, 2024, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    471
    Vidhi Khanna
    Oct 1, 2024